NAD+ precursors
- Evidence
- See canonical profiles
- Human data
- Human biomarker and population-specific outcomes
- Key limitation
- Biochemical changes do not establish longer lifespan
Goal guide
Healthy aging research
Compare supplements discussed in healthy-aging research by the human outcomes actually studied. Biomarkers, NAD+ changes, antioxidant activity, sirtuin signaling, and senolytic mechanisms are not evidence that a supplement extends human lifespan or slows aging.
Quick picks
Match your situation
Review cardiovascular outcome context
CoQ10
Review limited human resveratrol evidence
Resveratrol
Separate quercetin mechanisms from outcomes
Quercetin
Options compared
Sorted by how people usually approach this goal. “Why people stop” is included because the reason a supplement gets abandoned is usually more useful than its best-case claim.
| Option | Best for | Onset | Evidence | Risk | Why people stop |
|---|---|---|---|---|---|
| Resveratrol | Reviewing human metabolic and cardiovascular-marker studies, not lifespan extension | Study durations vary; no established anti-aging onset | Limited and outcome-specific in humans; no established human lifespan benefit | Low to moderate | No reliable subjective anti-aging effect and uncertain long-term payoff |
| CoQ10 | Reviewing cardiovascular and mitochondrial-related human outcomes | Weeks in studied cardiovascular and fatigue contexts | Outcome-specific human evidence; not evidence of slower aging or longer lifespan | Low | Slow feedback, cost, or no clear benefit for the outcome being tracked |
| Quercetin | Reviewing human evidence for specific outcomes while keeping senolytic claims preclinical | Study-dependent; no established anti-aging onset | No established human longevity benefit; senolytic framing is not a proven clinical anti-aging effect | Low | Uncertain human healthy-aging payoff and formulation/bioavailability concerns |
Resveratrol
Avoid if: Estrogen-sensitive conditions (phytoestrogen effect)
Form: Trans-resveratrol capsules
CoQ10
Avoid if: Blood clotting medications without monitoring
Form: Ubiquinol or water-soluble CoQ10 formulation
Quercetin
Avoid if: Severe kidney disease without clinician check
Form: Quercetin phytosome or paired with bromelain
Evidence at a glance
Summary tiers for quick scanning — open each profile for full sourcing and study context.
Resveratrol
- Evidence
- See canonical profile
- Human data
- Human and mechanistic evidence kept separate
- Key limitation
- Pathway or surrogate findings are not direct longevity outcomes
CoQ10
- Evidence
- See canonical profile
- Human data
- Population-specific human outcomes
- Key limitation
- Condition-specific findings should not become universal healthy-aging claims
Quercetin
- Evidence
- See canonical profile
- Human data
- Human, preclinical, and mechanism evidence separated
- Key limitation
- Senolytic or preclinical rationale is not proof of human longevity benefit
Dosing context (verify your label)
- Nicotinamide Riboside / NMN: Use only formulation- and study-specific dose context from canonical records; do not translate biomarker changes into lifespan claims.
- Resveratrol: Keep preparation, bioavailability, population, and endpoint limitations attached to any dose discussion.
- CoQ10: Interpret studied doses within the population and outcome actually researched rather than as a universal anti-aging dose.
Frequently asked questions
What does “healthy aging evidence” actually mean?
Separate direct human health outcomes from surrogate biomarkers, pathway measurements, animal findings, and cell studies. A change in a biomarker can be scientifically interesting without establishing that an intervention extends human lifespan or healthspan.
Does activating an aging-related pathway prove a supplement slows aging?
No. NAD+, sirtuin, mitochondrial, senolytic, and similar pathway findings are mechanistic evidence unless a human study measures a relevant clinical outcome. The site should label those mechanisms as mechanisms rather than converting them into longevity claims.
How should healthy-aging ingredients be compared?
Compare the exact human endpoint, population, study duration, formulation, safety record, and whether findings have been replicated. Do not rank ingredients by how futuristic or biologically plausible their mechanisms sound.
Why are long-term conclusions especially difficult in healthy-aging research?
Many studies are shorter than the time horizon implied by longevity claims and therefore rely on intermediate outcomes. Keep the gap between what a study measured and what a marketing claim implies visible.
Safety checklist
- Do not present biomarker movement, pathway activation, or animal lifespan findings as demonstrated human longevity benefit.
- Keep disease-treatment research distinct from general healthy-aging education and route medication-sensitive questions through the safety record.
- Prefer uncertainty over a forced ranking when long-term human outcome evidence is missing.
Optional sourcing notes
Sourcing examples for this goal
These are product examples to research carefully — not prescriptions and not a substitute for the safety notes above.
Sirtuin / pathway activation
Featured example
Jarrow Formulas — Jarrow Formulas Resveratrol 100 mg
Sourcing note: Product example for a standardized trans-resveratrol capsule in a clean formula.
- • Prefer third-party tested brands (USP, NSF, ConsumerLab, or published COA)
- • Standardized actives on the label — not proprietary blends only
- • Value = dose transparency + quality markers, not hype or lowest unit price alone
Affiliate link. Disclosure
Senolytic / immune support
Featured example
Jarrow Formulas — Jarrow Formulas Quercetin 500 mg
Sourcing note: Product example for a clean, pure quercetin dihydrate capsule at a reliable dose.
- • Prefer third-party tested brands (USP, NSF, ConsumerLab, or published COA)
- • Standardized actives on the label — not proprietary blends only
- • Value = dose transparency + quality markers, not hype or lowest unit price alone
Affiliate link. Disclosure
Related goals
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.